Back

ASCO Plenary Mar 2023 - ASCO Plenary Series: March 2023

Mar 22 - Mar 22, 2023 | AlexandriaVAUS

LARVOL is not affiliated with ASCO Plenary Series: March 2023 and all trademarks, logos, and brand names are property of their respective owners

Condition
Stage
Treatment
Setting
Biomarker
Trial Name/ID

Showing 1 titles linked to Trials

Zolbetuximab + CAPOX in 1L claudin-18.2+ (CLDN18.2+)/HER2− locally advanced (LA) or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW.

9 Twitter Reactions